Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients

BACKGROUND: New treatment modalities are needed for the treatment of cancers of the head and neck region (HNSCC). Survivin is important for the survival and proliferation of tumor cells and may therefore provide a target for immunotherapy. Here we focused on the ex vivo presence and in vitro inducti...

Descripción completa

Detalles Bibliográficos
Autores principales: Turksma, Annelies W, Bontkes, Hetty J, Ruizendaal, Janneke J, Scholten, Kirsten BJ, Akershoek, Johanneke, Rampersad, Shakila, Moesbergen, Laura M, Cillessen, Saskia AGM, Santegoets, Saskia JAM, de Gruijl, Tanja D, Leemans, C René, Meijer, Chris JLM, Hooijberg, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695847/
https://www.ncbi.nlm.nih.gov/pubmed/23787039
http://dx.doi.org/10.1186/1479-5876-11-152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695847/
https://www.ncbi.nlm.nih.gov/pubmed/23787039
http://dx.doi.org/10.1186/1479-5876-11-152

Ejemplares similares